Showing 346 to 360 of 1602 results
My Story - Dawn Starley
In celebration of LGBTQ+ History Month, Dawn shares what her experience has been both professionally and personally and why Equality, Diversity and Inclusion is critical for ensuring all members of society are given a fair chance to be themselves and flourish.
Insights and data
Data and statistics on our regulatory work, including information on fitness to practise, registration and education processes
Resources on record keeping
We have listed the main resources that we signpost registrants to, when they have a question about record keeping
What you need to know about being an expert witness
Being an expert witness is an opportunity to demonstrate high levels of expertise and professionalism in your own area of practise
HCPC response to PSA Performance Review
HCPC welcomes recognition of progress on key areas of activity and sets out plan for further improvement
Registration FAQs
Some of the questions we most frequently get asked by registrants
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)